PNPLA3 and metabolic dysfunction-associated steatotic liver disease: In particular, prior research has demonstrated that patatin-like phospholipase domain containing 3 gene (PNPLA3 at Chr22q13.3) variants are associated with elevated serum aminotransferase levels [35–37] and heightened risk for NAFLD [26, 38].